Effect of oral anticoagulants on the outcome of faecal immunochemical test

被引:30
作者
Bujanda, L. [1 ]
Sarasqueta, C. [2 ]
Lanas, A. [3 ]
Quintero, E. [4 ]
Cubiella, J. [5 ]
Hernandez, V. [6 ]
Morillas, J. D. [7 ]
Perez-Fernandez, T. [8 ]
Salas, D. [9 ]
Andreu, M. [10 ]
Carballo, F. [11 ]
Bessa, X. [10 ]
Portillo, I. [12 ]
Jover, R. [13 ]
Balaguer, F. [14 ]
Cosme, A. [1 ]
Castells, A. [14 ]
机构
[1] Univ Pais Vasco UPV EHU, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Hosp Univ Donostia, Dept Gastroenterol,Inst Biodonostia, San Sebastian, Spain
[2] Hosp Univ Donostia, Inst Biodonostia, Red Invest Serv Salud Enfermedades Cron REDISSEC, San Sebastian, Spain
[3] Univ Zaragoza, Dept Gastroenterol, IIS Aragon, CIBERehd, Zaragoza, Spain
[4] Univ La Laguna, Hosp Univ Canarias, Dept Gastroenterol, Tenerife, Spain
[5] Complexo Hosp Univ Ourense, Dept Gastroenterol, Orense, Spain
[6] Complexo Hosp Univ Vigo, Serv Aparato Digest, Vigo, Spain
[7] Hosp Clin San Carlos, Dept Gastroenterol, Madrid, Spain
[8] Hosp Fdn Alcorcon, Dept Gastroenterol, Madrid, Spain
[9] Conselleria Sanitat, Programa Cribado Canc Colorrectal, Direcc Gen Salud Publ, Valencia, Spain
[10] IMIM, Hosp del Mar, Dept Gastroenterol, Barcelona, Catalonia, Spain
[11] Hosp Univ Virgen de la Arrixaca, Unidad Gest Clin Digest, Murcia, Spain
[12] Org Cent Osakidetza Serv Vasco Salud, Programa Cribado Canc Colorrectal, Bilbao, Spain
[13] Hosp Gen Univ Alicante, Dept Gastroenterol, Alicante, Spain
[14] Univ Barcelona, IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Dept Gastroenterol,Hosp Clin, Barcelona, Catalonia, Spain
关键词
faecal immunochemical test; FIT; oral anticoagulant; advanced neoplasia; colorectal cancer screening; OCCULT BLOOD-TEST; LOW-DOSE ASPIRIN; COLORECTAL-CANCER; COLONOSCOPY; WARFARIN; DRUGS;
D O I
10.1038/bjc.2014.38
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We aimed to evaluate whether oral anticoagulants (OACs) alter faecal immunochemical test (FIT) performance in average-risk colorectal cancer (CRC) screening. Methods: Individuals aged 50-69 years were invited to receive one FIT sample (cutoff 75 ng ml(-1)) between November 2008 and June 2011. Results: Faecal immunochemical test was positive in 9.3% (21 out of 224) of users of OAC and 6.2% (365 out of 5821) of non-users (P-trend = 0.07). The positive predictive value (PPV) for advanced neoplasia (AN) in non-users was 50.4% vs 47.6% in users (odds ratio, 0.70; 95% CI, 0.3-1.8; P = 0.5). The PPV for AN in OAC more antiplatelets (aspirin or clopidogrel) was 75% (odds ratio, 2; 95% CI, 0.4-10.8; P = 0.4). Conclusions: Oral anticoagulant did not significantly modify the PPV for AN in this population-based colorectal screening program. The detection rate of advanced adenoma was higher in the combination OAC more antiplatelets.
引用
收藏
页码:1334 / 1337
页数:4
相关论文
共 10 条
  • [1] Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy
    Blacker, DJ
    Wijdicks, EFM
    McClelland, RL
    [J]. NEUROLOGY, 2003, 61 (07) : 964 - 968
  • [2] Effect of Aspirin and Antiplatelet Drugs on the Outcome of the Fecal Immunochemical Test
    Bujanda, Luis
    Lanas, Angel
    Quintero, Enrique
    Castells, Antoni
    Sarasqueta, Cristina
    Cubiella, Joaquin
    Hernandez, Vicent
    Morillas, Juan D.
    Perez-Fernandez, Teresa
    Salas, Dolores
    Andreu, Montserrat
    Carballo, Fernando
    Bessa, Xavier
    Cosme, Angel
    Jover, Rodrigo
    [J]. MAYO CLINIC PROCEEDINGS, 2013, 88 (07) : 683 - 689
  • [3] Prevalence and Implications of Preinjury Warfarin Use An Analysis of the National Trauma Databank
    Dossett, Lesly A.
    Riesel, Johanna N.
    Griffin, Marie R.
    Cotton, Bryan A.
    [J]. ARCHIVES OF SURGERY, 2011, 146 (05) : 565 - 570
  • [4] A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for Hemoglobin
    Fraser, Callum G.
    Allison, James E.
    Halloran, Stephen P.
    Young, Graeme P.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (11): : 810 - 814
  • [5] Clinical practice Guidelines: quality of colonoscopy in colorectal cancer screening
    Jover, R.
    Herraiz, M.
    Alarcon, O.
    Brullet, E.
    Bujanda, L.
    Bustamante, M.
    Campo, R.
    Carreno, R.
    Castells, A.
    Cubiella, J.
    Garcia-Iglesias, P.
    Hervas, A. J.
    Menchen, P.
    Ono, A.
    Panades, A.
    Parra-Blanco, A.
    Pellise, M.
    Ponce, M.
    Quintero, E.
    Rene, J. M.
    del Rio, A. Sanchez
    Seoane, A.
    Serradesanferm, A.
    Izquierdo, A. Soriano
    Sequeiros, E. Vazquez
    [J]. ENDOSCOPY, 2012, 44 (04) : 444 - 451
  • [6] Sensitivity, but Not Specificity, of a Quantitative Immunochemical Fecal Occult Blood Test for Neoplasia Is Slightly Increased by the Use of Low-Dose Aspirin, NSAIDS, and Anticoagulants
    Levi, Zohar
    Rozen, Paul
    Hazazi, Rachel
    Vilkin, Alex
    Waked, Amal
    Maoz, Eran
    Birkenfeld, Shlomo
    Lieberman, Nicky
    Klang, Shmuel
    Niv, Yaron
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (04) : 933 - 938
  • [7] Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
    Levin, Bernard
    Lieberman, David A.
    McFarland, Beth
    Andrews, Kimberly S.
    Brooks, Durado
    Bond, John
    Dash, Chiranjeev
    Giardiello, Francis M.
    Glick, Seth
    Johnson, David
    Johnson, C. Daniel
    Levin, Theodore R.
    Pickhardt, Perry J.
    Rex, Douglas K.
    Smith, Robert A.
    Thorson, Alan
    Winawer, Sidney J.
    [J]. GASTROENTEROLOGY, 2008, 134 (05) : 1570 - 1595
  • [8] Anticoagulant or aspirin treatment does not affect the positive predictive value of an immunological fecal occult blood test in patients undergoing colorectal cancer screening: results from a nested in a cohort case-control study
    Mandelli, Giovanna
    Radaelli, Franco
    Paggi, Silvia
    Terreni, Natalia
    Gola, Gemma
    Gramegna, Maria
    Bonaffini, Antonino
    Terruzzi, Vittorio
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (04) : 323 - 326
  • [9] Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]
  • [10] Fecal Occult Blood Test in Patients on Low-Dose Aspirin, Warfarin, Clopidogrel, or Non-steroidal Anti-inflammatory Drugs
    Sawhney, Mandeep S.
    McDougall, Heather
    Nelson, Douglas B.
    Bond, John H.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (06) : 1637 - 1642